Mississauga, ON -- (SBWIRE) -- 05/12/2015 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "Relmada Therapeutics Receives Notice of Allowance for U.S. Patent Covering SECUREL."
Companies mentioned in this article include Relmada Therapeutics Inc. (OTCQB:RLMD).
Article Excerpt:
In 2012, the chronic pain drug market was worth $21.4 billion. Decision Resources, a research and advisory firm, expects the market to decrease to $18.3 billion by 2017. However, the research firm sees a recovery thereafter and by 2022 the market is expected to be worth $21.6 billion in the U.S., France, Germany, Italy, Spain, the U.K., and Japan.
The initial contraction in the chronic pain treatment market will be due to the loss of market exclusivity for a number of key chronic pain therapies. The recovery though will be driven by the launch of several new therapies.
Decision Resources, citing a report called Chronic Pain, notes that the pipeline of therapies in development continues to be composed mainly of reformulations of existing molecules. However, some companies are also developing novel versions of proven drug products with new chemical entities.
One such company is Relmada Therapeutics Inc. (OTCQB:RLMD). Based in New York City, RLMD has a diversified portfolio of four products, which are at different stages of development. In addition, the company has an early stage pipeline of four products.
The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/533/relmada-therapeutics-receives-notice-of-allowance-for-us-patent-covering-securel.htm
About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: 905-361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.